These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6715915)

  • 1. Poly ICLC induces anti-IC antibodies in mice and rabbits.
    Granados EN; Alm T; O'Malley JA; McGarry M; Bello J
    J Interferon Res; 1984; 4(1):57-62. PubMed ID: 6715915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
    Pessina GP; Muscettola M; Paulesu L; Bocci V
    J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characterization of MVE-2 and poly ICLC.
    Schlick E; Welker R; Piccoli M; Ruffmann R; Chirigos M
    Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC.
    Chirigos MA; Welker R; Schlick E; Saito T; Ruffmann R
    Prog Clin Biol Res; 1984; 161():467-79. PubMed ID: 6483899
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
    Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
    Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulating effects of poly ICLC.
    Levy HB; Lvovsky E; Riley F; Harrington D; Anderson A; Moe J; Hilfenhaus J; Stephen E
    Ann N Y Acad Sci; 1980; 350():33-41. PubMed ID: 6972185
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
    Loewen KG; Derbyshire JB
    Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.
    Williams BB; Paul RT; Lerner AM
    J Infect Dis; 1982 Dec; 146(6):819-25. PubMed ID: 6183371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor response to interferon inducer and radiation effect of serum interferon levels.
    Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
    J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of interferon induction by poly ICLC in humans.
    Bever CT; McFarland HF; McFarlin DE; Levy HB
    J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of virus-induced murine diabetes by an interferon inducer.
    Gadzik JP; Naji A; Barker CF; Blank KJ
    J Interferon Res; 1982; 2(1):59-63. PubMed ID: 6286804
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of hematopoietic stem cells by interferon inducer in nonhuman primates receiving fractionated total body irradiation.
    Lvovsky EA; Levine PH; Bengali Z; Leiseca SA; Cicmanec JL; Robinson JE; Bautro N; Levy HB; Scott RM
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1721-6. PubMed ID: 6759479
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of interferon induction in newborn piglets on the humoral immune response to oral vaccination with transmissible gastroenteritis virus.
    Derbyshire JB; Lesnick CE
    Vet Immunol Immunopathol; 1990 Mar; 24(3):227-34. PubMed ID: 1692649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of carboxymethylcellulose decreases toxicity of poly ICLC in mice.
    Bello J; O'Malley J; Granados E
    J Interferon Res; 1985; 5(3):429-30. PubMed ID: 4056490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon induction and therapy of brain tumors in rats by poly(ICLC).
    Machida H; Takezawa J; Kuninaka A; Yoshino H; Nakamura O; Takakura K
    Microbiol Immunol; 1982; 26(4):353-8. PubMed ID: 6180284
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of interferon responses to poly ICLC in males and females.
    Bever CT; McFarlin DE; Levy HB
    J Interferon Res; 1985; 5(3):423-8. PubMed ID: 2414373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
    Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
    No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
    Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
    Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
    Stringfellow DA; Weed SD
    Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of toll-like receptor signaling pathway for protection against influenza virus infection.
    Wong JP; Christopher ME; Viswanathan S; Karpoff N; Dai X; Das D; Sun LQ; Wang M; Salazar AM
    Vaccine; 2009 May; 27(25-26):3481-3. PubMed ID: 19200852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.